York Pharma Share Discussion Threads

[topinfo] 02/3/2009 23:46

8Trader...Yet another one here you have missed. No pump and dump here, in from 2p and offer now for the company. This will hit 8p 2moro and you my friend will once again have made nothing. CDN will make you lots of money in medium to short term but today a bad day for everything...except of course YRK which you own none....LOL.!!!!

[8trader] 02/3/2009 18:39

I see your CDN pump and dump did not do very well TI.

Have you ever considered just posting that you are looking for a 20%
rise in a stock, you know what i mean, the actually price that you sell
for or less when posting this drivel of 100-1000% price targets ?

[topinfo] 02/3/2009 16:54

Fallen from 200p to 2p and still has loads of potential.

[topinfo] 02/3/2009 16:53

Take out share price must be at least 10-15p and someone will get a right bargain for their money. Can see this opening around 8p first thing 2moro as news came out late as mkt was closing and not many peeps had time to react.

[ursamajorra] 02/3/2009 16:34

And explode they did.(-;

[ursamajorra] 02/3/2009 16:29

RNS Number : 1570O
York Pharma plc
02 March 2009

?
Not for release, publication or distribution in whole or in part, in or into the
United States, Canada,
Australia, Japan or the Republic of Ireland




York Pharma plc
(the "Company")


Statement concerning Possible Offer and Rule 2.10 announcement


The Board of the Company notes the recent movement in the Company's share price
and confirms that the Company has made an approach to a potential offeror which
may or may not lead to an offer being made for the Company. The Board of the
Company, which is being advised by Collins Stewart Europe Limited, wishes to
stress that these discussions are at a very early stage and there can be no
certainty that this approach will lead to an offer being made for the Company.

[latifs100] 28/2/2009 12:10

wots cash and debt levels..tia

[wetdream] 28/2/2009 11:41

Do you mean a quid for the whole company?
;-)

[ursamajorra] 27/2/2009 11:44

Wonder if we get back to a quid??

[ursamajorra] 27/2/2009 11:40

All aboard.

This thread is 4 years old.

[ursamajorra] 27/2/2009 11:38

The recently strengthened management team has now assessed the current position
of the Company and initiated steps to simplify and focus the existing business.
As a consequence the Board has agreed the following actions:


* The closure of York's existing representative office in Japan with immediate
effect;



* A significant reduction of the Company's existing infrastructure in Germany;



* A review of the development pipeline to identify assets within the portfolio to
be divested; and



* To continue the development of the late stage dermatology pipeline whilst
minimising the investment required by the Company


The new management team has moved swiftly to cut costs and to refocus the core
business. We are also moving ahead with the next phase of our plan which is to
build on the stable platform being created as a result of the restructuring so
as to establish a cash generative business. I believe that York remains an
attractive, revenue generating speciality pharmaceutical business with a strong
late stage pipeline.

[ursamajorra] 27/2/2009 11:19

Sold out at 80p back in at 2.5p.

Fingers crossed.

Sh!t or bust.

[risk1] 26/2/2009 19:12

mm

nice

[wetdream] 26/2/2009 15:15

Sadler's got over 2 million of these. Should be one helluva bonfire!

[wetdream] 25/2/2009 19:47

Directors' pay: AIM's rich list
Nov 08 issue

CEOs at AIM's profitable companies received an eight per cent pay rise this year, while loss makers enjoyed a 30 per cent hike.
Oliver Haill looks for method in the madness

The chief executives of the UK's most high-profile growth companies last year increased their pay by 15 per cent – over three times the current rate of inflation. On average, a chief executive on the Alternative Investment Market (AIM), the London Stock Exchange's junior market for fast-growing companies, receives £268,036, representing a 54 per cent leap from 2006 and a 100 per cent advance on the £134,000 paid in 2003.

Cashing in
Despite widespread criticism about the bonus structure of City institutions, 24 CEOs of AIM companies were rewarded with more than £1 million. Furthermore, of the 86 CEOs who took home over £500,000, 27 had overseen a loss-making year.

To delve further into the statistics, which were unearthed by our sister publication Growth Company Investor's Directors' Pay on AIM 2008 report, the average pay of a chief executive leading a profitable venture was £324,050, up eight per cent from the previous year. Growth in remuneration at those companies losing money was even higher, with the CEO's average pay up 30 per cent to £223,148.

Frank Lewis, a serial non-executive who has sat on a dozen boards and is a member of the AIM Advisory Group, says, 'I don't believe executives who receive huge pay packets for making large losses deserve it. There needs to be a change in attitude so that if you succeed you're rewarded, but if you fail you're not.'

Risk and reward
The task for remuneration committees is hardly easy. With small, loss-making companies it is perhaps most difficult to find a balance between rewarding and retaining a good executive and not spending too much of the company's precious cash.

'At loss-making companies cash flow is obviously a big problem,' concedes Lewis. 'It's very difficult to set wages, but the culture of rewarding people with bonuses for losses is ridiculous. You should reward people only for positive achievements.

'People generally think they're worth more than they're paid, and also that their bonuses are not enough, but in today's environment I think they have to wake up and take a different view – although what the answer is I don't know.'

Millionaires' club
The increasing adoption of bonuses is one reason why AIM pay is accelerating so rapidly. Each and every one of the best-paid executives had their salary topped up by a bonus and many by additional share-based payments. This has seen AIM executive pay accelerate much faster than that of the UK's blue-chips.

Recent research by The Guardian and Reward Technology Forum found that boardroom pay among FTSE 100 companies increased by a much slower five per cent to £979.2 million over the past year. Though the gap between AIM and the top tier of the British market is large, the £1.45 million average pay of a chief executive of a FTSE 250 company (although pension contributions were excluded) is surpassed by 11 AIM chief executives.

The AIM company with the costliest remuneration structure is hedge fund manager RAB Capital (the same as last year) which provides a CEO salary of £102,000, swelled by a £7.7 million bonus. The company improved its profits during the year to £51.1 million and the remuneration committee, made up entirely of non-executive directors, decided to distribute 54 per cent of this to the employee bonus pool.

Coming in as the second largest package was the £5.1 million received by the finance director of oil explorer Dominion Petroleum. This was in a year when the pre-revenue company lost $25 million (£16.6 million) before tax and its shares ended up at a similar level to where they started. In this case $8.5 million of share-based payments were added to the $203,000 basic salary.

..............

For more information about the full, comprehensive report, Directors' Pay on AIM, contact Danica Pasinis on 020 7250 7039 or email [e-mail]

[risk1] 10/2/2009 21:02

thanks topvest

just a punt for me dyor

[topvest] 10/2/2009 20:50

I think York is on its last legs - beware!

[risk1] 10/2/2009 20:40

err imo dyor

[tpain] 10/2/2009 20:34

risk1 - 10 Feb'09 - 20:33 - 2642 of 2642 (Filtered)

No one take this man's advice.

He nearly lost me £15k on another stock.

[risk1] 10/2/2009 20:33

go where others fear imo dyor